Emerging Drugs of Abuse
Authors:
- Rachel HarozRHRachel Haroz
- Michael I. GreenbergMGMichael I. Greenberg
- 1 November 2005
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 89 (6) , 1259-1276
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- N-Substituted Piperazines Abused by Humans Mimic the Molecular Mechanism of 3,4-Methylenedioxymethamphetamine (MDMA, or ‘Ecstasy’)Neuropsychopharmacology, 2004
- Hallucinogens and dissociative agents naturally growing in the United StatesPharmacology & Therapeutics, 2004
- A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugsPharmacy World & Science, 2004
- Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone TypesTherapeutic Drug Monitoring, 2004
- A2 (N-Benzylpiperazine) a New Drug of Abuse in SwedenJournal of Analytical Toxicology, 2004
- Foxy, a Designer Tryptamine Hallucinogen*Journal of Analytical Toxicology, 2003
- Plants and the central nervous systemPharmacology Biochemistry and Behavior, 2003
- Piperazine-like compounds: a new group of designer drugs-of-abuse on the European marketForensic Science International, 2001
- Amphetamine designer drugs – an overview and epidemiologyToxicology Letters, 2000
- More Data About the New Psychoactive Drug 2C-BJournal of Analytical Toxicology, 1999